Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment

Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment

Abstract   Chronic Obstructive Pulmonary Disease (COPD) is a chronic airway inflammation with resulting progressive airflow limitation that has a high incidence, morbidity, and mortality. Roflumilast is an oral phosphodiesterase-4 inhibitor as a therapy to decrease the risk of COPD exacerbations in...

Full description

Bibliographic Details
Main Authors: Ita Octafia, Dwi Octamy Sari, Novi Wulandari, Sandra Annisa, Linda Wahyuni Wongkar, Ferdias Kurnia Bahari, Faiz Farikhah, Moh Firmansah, Erfin Midhiawati, Fauna Herawati
Format: Article
Language:Indonesian
Published: Universitas Muhammadiyah Surabaya 2021-01-01
Series:Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya
Subjects:
copd, roflumilast, phosphodiesterase-4 inhibitor, treatment
Online Access:http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/5043

Internet

http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/5043

Similar Items